181 related articles for article (PubMed ID: 34176443)
1. Synthesis, antioxidant,
Siddiqa A; Tajammal A; Irfan A; Munawar MA; Azam M; Basra MAR
J Biomol Struct Dyn; 2022; 40(20):10265-10277. PubMed ID: 34176443
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Keap1-Nrf2 small-molecule inhibitors from phytochemicals based on molecular docking.
Li M; Huang W; Jie F; Wang M; Zhong Y; Chen Q; Lu B
Food Chem Toxicol; 2019 Nov; 133():110758. PubMed ID: 31412289
[TBL] [Abstract][Full Text] [Related]
4. LC-MS characterized methanolic extract of zanthoxylum armatum possess anti-breast cancer activity through Nrf2-Keap1 pathway: An in-silico, in-vitro and in-vivo evaluation.
Sahu R; Kar RK; Sunita P; Bose P; Kumari P; Bharti S; Srivastava S; Pattanayak SP
J Ethnopharmacol; 2021 Apr; 269():113758. PubMed ID: 33359860
[TBL] [Abstract][Full Text] [Related]
5. Isoflavone biochanin A, a novel nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element activator, protects against oxidative damage in HepG2 cells.
Liang F; Cao W; Huang Y; Fang Y; Cheng Y; Pan S; Xu X
Biofactors; 2019 Jul; 45(4):563-574. PubMed ID: 31131946
[TBL] [Abstract][Full Text] [Related]
6. Ginnalin A Binds to the Subpockets of Keap1 Kelch Domain To Activate the Nrf2-Regulated Antioxidant Defense System in SH-SY5Y Cells.
Zhang Z; Peng L; Fu Y; Wang W; Wang P; Zhou F
ACS Chem Neurosci; 2021 Mar; 12(5):872-882. PubMed ID: 33571414
[TBL] [Abstract][Full Text] [Related]
7. Characterization of novel small-molecule NRF2 activators: Structural and biochemical validation of stereospecific KEAP1 binding.
Huerta C; Jiang X; Trevino I; Bender CF; Ferguson DA; Probst B; Swinger KK; Stoll VS; Thomas PJ; Dulubova I; Visnick M; Wigley WC
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2537-2552. PubMed ID: 27474998
[TBL] [Abstract][Full Text] [Related]
8. Identification and molecular mechanisms of novel antioxidant peptides from two sources of eggshell membrane hydrolysates showing cytoprotection against oxidative stress: A combined in silico and in vitro study.
Zhu L; Xiong H; Huang X; Guyonnet V; Ma M; Chen X; Zheng Y; Wang L; Hu G
Food Res Int; 2022 Jul; 157():111266. PubMed ID: 35761579
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model.
Kim S; Indu Viswanath AN; Park JH; Lee HE; Park AY; Choi JW; Kim HJ; Londhe AM; Jang BK; Lee J; Hwang H; Lim SM; Pae AN; Park KD
Neuropharmacology; 2020 May; 167():107989. PubMed ID: 32032607
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions.
Lu MC; Shao HL; Liu T; You QD; Jiang ZY
Eur J Med Chem; 2020 Dec; 207():112734. PubMed ID: 32866756
[TBL] [Abstract][Full Text] [Related]
11. Esculetin induces antiproliferative and apoptotic response in pancreatic cancer cells by directly binding to KEAP1.
Arora R; Sawney S; Saini V; Steffi C; Tiwari M; Saluja D
Mol Cancer; 2016 Oct; 15(1):64. PubMed ID: 27756327
[TBL] [Abstract][Full Text] [Related]
12. Molecular recognition between potential natural inhibitors of the Keap1-Nrf2 complex.
Bello M; Morales-González JA
Int J Biol Macromol; 2017 Dec; 105(Pt 1):981-992. PubMed ID: 28746889
[TBL] [Abstract][Full Text] [Related]
13. NRF2 activation by reversible KEAP1 binding induces the antioxidant response in primary neurons and astrocytes of a Huntington's disease mouse model.
Moretti D; Tambone S; Cerretani M; Fezzardi P; Missineo A; Sherman LT; Munoz-Sajuan I; Harper S; Dominquez C; Pacifici R; Tomei L; Park L; Bresciani A
Free Radic Biol Med; 2021 Jan; 162():243-254. PubMed ID: 33096251
[TBL] [Abstract][Full Text] [Related]
14. The Keap1/Nrf2-ARE Pathway as a Pharmacological Target for Chalcones.
de Freitas Silva M; Pruccoli L; Morroni F; Sita G; Seghetti F; Viegas C; Tarozzi A
Molecules; 2018 Jul; 23(7):. PubMed ID: 30037040
[TBL] [Abstract][Full Text] [Related]
15. Novel diterpenoid-type activators of the Keap1/Nrf2/ARE signaling pathway and their regulation of redox homeostasis.
Li AL; Shen T; Wang T; Zhou MX; Wang B; Song JT; Zhang PL; Wang XL; Ren DM; Lou HX; Wang XN
Free Radic Biol Med; 2019 Sep; 141():21-33. PubMed ID: 31167117
[TBL] [Abstract][Full Text] [Related]
16. Bis-Michael Acceptors as Novel Probes to Study the Keap1/Nrf2/ARE Pathway.
Deny LJ; Traboulsi H; Cantin AM; Marsault É; Richter MV; Bélanger G
J Med Chem; 2016 Oct; 59(20):9431-9442. PubMed ID: 27682717
[TBL] [Abstract][Full Text] [Related]
17. Activation of kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2/antioxidant response element pathway by curcumin enhances the anti-oxidative capacity of corneal endothelial cells.
Guo SP; Chang HC; Lu LS; Liu DZ; Wang TJ
Biomed Pharmacother; 2021 Sep; 141():111834. PubMed ID: 34153850
[TBL] [Abstract][Full Text] [Related]
18. NF-κB and Keap1 Interaction Represses Nrf2-Mediated Antioxidant Response in Rabbit Hemorrhagic Disease Virus Infection.
Hu B; Wei H; Song Y; Chen M; Fan Z; Qiu R; Zhu W; Xu W; Wang F
J Virol; 2020 May; 94(10):. PubMed ID: 32161178
[TBL] [Abstract][Full Text] [Related]
19. Identification and molecular mechanisms of novel antioxidant peptides from fermented broad bean paste: A combined in silico and in vitro study.
Lin H; Zhao J; Xie Y; Tang J; Wang Q; Zhao J; Xu M; Liu P
Food Chem; 2024 Aug; 450():139297. PubMed ID: 38631199
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant Activity of Novel Casein-Derived Peptides with Microbial Proteases as Characterized via Keap1-Nrf2 Pathway in HepG2 Cells.
Zhao X; Cui YJ; Bai SS; Yang ZJ; Miao-Cai ; Megrous S; Aziz T; Sarwar A; Li D; Yang ZN
J Microbiol Biotechnol; 2021 Aug; 31(8):1163-1174. PubMed ID: 34226415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]